|
|
|
|
- Theraclion has received US FDA clearance to begin a new pivotal clinical trial testing the Sonovein® device for the treatment of primary insufficiency of great saphenous veins.
- The multicenter study, called VEINRESET, will take place at four centers in the US and Europe.
|
|
|
|
|
|
|
|
|
|
|
|
- Alice served the Foundation as a friend, mentor, advocate, donor, investment committee member, and Council member.
- She died on May 30 from complications related to early-stage dementia.
- This story is accompanied by a special tribute from Alice’s fellow Investment Committee member, Dick Mayo.
|
|
|
|
|
|
|
|
|
|
|
|
- A research team has published a preclinical study showing that focused ultrasound plus microbubbles can enhance glymphatic clearance in the brain.
- This work has implications for treating stroke, Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
- There are currently no noninvasive ways to access the glymphatic system in humans.
|
|
|
|
|
|
|
|
|
|
|
|
- An open-access collection of new articles, called “Neuroethics and Developing Brain Technology,” has been published.
- The series addresses real and challenging ethical questions in neuroscience research and clinical care.
- The Foundation prioritizes ethical issues to keep them at the forefront of the focused ultrasound community.
|
|
|
|
|
|
|
|
|
|
|
|
- Three organizations are seeking proposals for research projects related to two neurological diseases: epilepsy and ALS.
- The deadlines to apply for these grants are June 26 through June 30.
|
|
|
|
|
|
|
|
|
And Don't Miss...
|
Register for a Webinar | “Ablation” by Professor Sébastien Crouzet from the University Hospital of Lyon Edouard Herriot Hospital | June 15 at 11:00 am Eastern
|
|
|
|
|
|
|
|
Events
|
|
|
|
|
|
|
|
|
|
|
|
|
“Alice was a person who made the world a better place. Every person and institution she touched was fortunate and better for her involvement.”
‒ Neal F. Kassell, MD |
|
|
|
|
|
|